Centre of Excellence in Molecular Biology

What Centre of Excellence in Molecular Biology does

Centre of Excellence in Molecular Biology (CEMB) is a government-affiliated academic research institute established in 1986 under the University of the Punjab in Lahore, Pakistan. It operates 40+ specialized laboratories across applied and functional genomics, biopharmaceuticals and proteomics, forensic DNA analysis, genetic diseases, plant biotechnology, stem cell research, and virology, employing 101-250 staff and 243 researchers recognized in the world's Top 2% Scientists list. The institute's portfolio spans three verticals: agricultural biotechnology (notably the Punjab Seed Council-approved transgenic triple gene cotton variety CEMB-CKC-05 and transgenic mosquito larvicidal algae), biopharmaceuticals (indigenously developed Filgrastim biosimilar for neutropenia and PAKZYME PCR enzymes), and human health services (genetic screening, DNA sequencing on Sanger and NGS platforms, cytotoxicity analysis, forensic DNA typing, and stem cell research).

CEMB's revenue model is hybrid and primarily public-sector: core funding flows from the Higher Education Commission (HEC) of Pakistan and the University of the Punjab, supplemented by competitive research grants (NRPU), tuition from M.Phil and Ph.D. programs, technology transfer licensing (Filgrastim to The Searle Company and Ferozsons Laboratories), laboratory diagnostic and testing services, and commercial product sales through registered startups such as PAKZYME. Distribution occurs through direct academic admissions, on-site laboratory services, technology transfer agreements with pharmaceutical industry, and international research collaborations with partners in China, Turkey, the USA, and Europe. The go-to-market is event-driven and community-led, relying on academic reputation, peer networks, government recognition, scientific conferences, and training workshops rather than conventional commercial sales motions.

Name

Centre of Excellence in Molecular Biology

Legal name

Centre of Excellence in Molecular Biology

Website

https://cemb.edu.pk

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

101–250 employees

Short description

Centre of Excellence in Molecular Biology is a University of the Punjab-affiliated research institute in Lahore, Pakistan, operating 40+ labs across genomics, biopharmaceuticals, plant biotechnology, stem cell, and forensic DNA. It serves graduate students, agricultural sector, pharmaceutical industry, and government agencies through research, technology transfer, and diagnostic services.

Ownership category

akta.pro rank

Product category

Biotechnology Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Transcriptomics & Gene Expression Profiling Services (HLAGANAE)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

Keywords

• Molecular biology research
• Biopharmaceutical products
• Agricultural biotechnology
• Genetic diagnostic services
• Forensic DNA analysis

Headquarters

HQ city

Lahore

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Academic Programs: Tuition and fees from M.Phil and Ph.D. programs in molecular biology
2. Government Funding: Core funding from Higher Education Commission of Pakistan (HEC) and University of the Punjab
3. Research Grants: National Research Program for Universities (NRPU) and other competitive research grants
4. Technology Transfer: Commercialization of developed products including Filgrastim biosimilar technology transfer to pharmaceutical companies The Searle Company and Ferozsons Laboratories
5. Testing and Diagnostic Services: Laboratory services including genetic screening, DNA sequencing, and molecular diagnostics
6. Commercial Products: Sale of PAKZYME PCR enzymes and research antibodies developed by startups

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Centre of Excellence in Molecular Biology (CEMB) is a research institute affiliated with the University of the Punjab that conducts molecular biology research and delivers a portfolio of biopharmaceutical products (PAKZYME PCR enzymes, Filgrastim biosimilar), agricultural biotechnology products (CEMB-CKC-05 transgenic cotton), specialized laboratory services (DNA sequencing, GMO analysis, forensic DNA typing, genetic disease diagnostics, stem cell research), and graduate academic programs (M.Phil and Ph.D.) in molecular biology.

Product overview

Centre of Excellence in Molecular Biology (CEMB) is a research institution affiliated with the University of the Punjab offering a diverse portfolio of molecular biology products and services. The portfolio includes biopharmaceutical products such as PAKZYME (indigenous PCR enzymes) and Filgrastim (biosimilar therapeutic for neutropenia); agricultural biotechnology products including the approved transgenic cotton variety CEMB-CKC-05; and specialized research and diagnostic services spanning genetic diseases diagnostics, forensic DNA typing, stem cell research, DNA sequencing (Sanger and NGS), cytotoxicity analysis, and molecular diagnostics. These offerings are delivered through distinct laboratory units including Applied and Functional Genomics Lab, Biopharmaceuticals and Proteomics Lab, Forensic Research Lab, Genetic Diseases Research Lab, Genetic Screening Lab, Medical and Environmental Biotechnology Lab, Plant Biotechnology Lab, Plant Genomics Lab, Seed Biotechnology Lab, Stem Cell Research Lab, Virology Lab, and Nutraceutical & Microbial Biotechnology Lab.

Differentiator

Problem solved

Functional benefit

Products and services

• PAKZYME

Quantifiable outcome

• 100% larval death of dengue virus carrier mosquito Aedes aegypti with transgenic algae technology
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

17 partnerships are on record, tiered core, major and minor.

• The Searle CompanycoreOEM/ Whitelabel/ Licensing Partner · 12 May 2026Technology transfer agreement for Filgrastim biosimilar therapeutic product for neutropenia treatment.
• Ferozsons LaboratoriescoreOEM/ Whitelabel/ Licensing Partner · 12 May 2026Technology transfer agreement for Filgrastim biosimilar therapeutic product for neutropenia treatment.
• Yeditepe UniversitymajorStrategic or Co-development Partner · 5 May 2026Prof. Dr. Fikrettin Şahin from Yeditepe University, Turkey visited under COMSTECH Expert Service Programme to explore collaborative opportunities in biotechnology and translational research.
• Shihezi UniversitycoreStrategic or Co-development Partner · 24 December 2025MoU signed between CEMB and Shihezi University, Xinjiang, China for advanced research in health sciences. Framework established for joint research initiatives and student exchanges.
• Xinjiang CDC (Center for Disease Control)coreStrategic or Co-development Partner · 24 December 2025Comprehensive discussions on public health challenges and collaborative strategies between Pakistan and China for disease prevention and control.
• TECON PharmaceuticalsmajorStrategic or Co-development Partner · 24 December 2025Prof. Moazur Rahman visited TECON Production Facilities in Urumqi to explore potential collaborative opportunities in pharmaceutical development.
• Xinjiang Agricultural UniversitymajorStrategic or Co-development Partner · 24 December 2025Discussions on potential collaboration in stem cells, infectious diseases, and herbal medicines research.
• China Agricultural UniversitycoreStrategic or Co-development Partner · 20 December 2025Participation in International Symposium on Veterinary Vaccine and Drug Technology Cooperation Among Belt and Road Countries. Collaboration in major animal disease control research.
• MIDAScoreStrategic or Co-development Partner · 16 January 2025CEMB collaborates with MIDAS for Stem Cell, Biopharmaceutical, and Genetic Diagnostics Commercialization.
• Punjab Thalassemia & Other Genetic Disorders Prevention & Research InstitutemajorStrategic or Co-development Partner · 14 January 2025MoU signed for collaboration in genetic disorders research and prevention initiatives.
• Four Brothers GroupmajorStrategic or Co-development Partner · 20 November 2024Chairman Four Brothers Group visited CEMB to foster collaboration on agricultural innovation.
• Pink Ribbon PakistanminorStrategic or Co-development Partner · 1 October 2024MoU signed for collaboration on breast cancer awareness and genetic screening initiatives.
• Bank AlFalahminorStrategic or Co-development Partner · 1 October 2024CEMB hosts awareness seminar on medical crops in collaboration with Bank AlFalah.
• LUMS (Lahore University of Management Sciences)majorStrategic or Co-development Partner · 25 September 2024Dr. Muhammad Tariq and Dr. Amir Faisal from LUMS visited CEMB to explore research and industrial collaboration opportunities. LUMS startup BIG specializes in antibody development.
• Evyol GroupmajorStrategic or Co-development Partner · 1 September 2024CEMB and Evyol Group join forces to innovate cotton production and boost agricultural prosperity.
• Guard Agricultural Research and ServicesmajorStrategic or Co-development Partner · 1 January 2024Collaborative agreement formalized for agricultural research and services in biotechnology.
• DAAD (German Academic Exchange Service)minorGTM or Marketing PartnerDAAD Delegation visited CEMB to explore collaboration opportunities in academic exchange.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• National Institute for Biotechnology and Genetic Engineering (NIBGE): Pakistan’s other premier biotechnology R&D center in Faisalabad, operating under federal government with parallel capabilities in agricultural biotech, microbial biotechnology, and genetic engineering — directly comparable in mission, funding model, and product portfolio to CEMB.
• International Centre for Genetic Engineering and Biotechnology (ICGEB): UN-affiliated research organization with campuses in Trieste, New Delhi, and Cape Town conducting molecular biology, genomics, and biotech research with a similar dual mission of basic research and capacity building for developing countries — directly comparable in research scope and translational focus.
• Institute of Molecular Biology, Academia Sinica: Taiwan’s premier molecular biology research institute within Academia Sinica focused on genomics, cell biology, and biotechnology — directly comparable to CEMB in molecular biology research scope and academic institutional structure.
• Indian Institute of Science Education and Research (IISER): Network of Indian government-funded research and education institutions with strong life sciences, genomics, and biotechnology programs producing PhD-level researchers — comparable to CEMB in academic graduate training mission and life sciences research output.
• A*STAR Institute of Molecular and Cell Biology (IMCB): Singapore’s flagship molecular biology institute conducting research in cell biology, genomics, and translational biotechnology with strong industry partnerships — comparable to CEMB in core research domains and translational ambitions, but with substantially larger scale and funding.
• Institute of Genomics and Integrative Biology (IGIB): CSIR lab in Delhi focused on genomics, molecular medicine, and bioinformatics with strong diagnostic service lines and translational research — directly comparable to CEMB’s genomics, genetic diagnostics, and translational biotech activities.
• National Centre for Cell Science (NCCS): Indian Department of Biotechnology autonomous research institute in Pune focused on cell biology, molecular biology, and stem cell research — closely comparable to CEMB’s stem cell, genomics, and molecular biology lab portfolio with parallel academic and translational mandates.

Broad incumbents

• Pasteur Institute: Historic French research institute with global network focused on infectious diseases, vaccines, and molecular biology — comparable in infectious disease, virology, and vaccine research but operates on a much broader and larger scale than CEMB.
• Korea Research Institute of Bioscience and Biotechnology (KRIBB): South Korean government-funded applied life sciences R&D institute with broad portfolios in biotech, biopharmaceuticals, and biofoundry — comparable in mission and government funding model but substantially larger scale and broader scope than CEMB.
• Chinese Academy of Sciences (CAS) Institutes: China’s national academy with numerous life sciences institutes conducting molecular biology, genomics, and agricultural biotech research — comparable in research domains but vastly larger scale; relevant given CEMB’s growing MoUs with Chinese institutions under Belt-and-Road.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@CEMBMedia
• Facebookfacebook.com/ncemb
• Instagraminstagram.com/lifeatcemb
• Xx.com/CentreCemb
• LinkedInlinkedin.com/company/cemb

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre of Excellence in Molecular Biology